Back to Work

Novartis · USPharma Division

USPharma Drupal Design System

In early 2022, Novartis was developing a new Drupal Design System for its US Pharma websites. As the UX Design Lead for this initiative, I oversaw a team of UI/UX Designers, Researchers, and Content Designers. Together, we designed, built, and tested all components to ensure they adhered to brand guidelines and created a scalable design system that could be applied across all Novartis Pharma websites.

The design system was launched on the Cosentyx website in late 2022, resulting in a 40% increase in average session duration, a 1% drop in bounce rate, and a 3% increase in pages per session.

Design Systems Healthcare UX Drupal CMS
Client Novartis
Role UX Strategy Lead
Platform Drupal CMS · Figma
Team CTS / TT / PPDD / UX Practice

What is the US Pharma Design System?

The US Pharma Drupal Design System is a set of pre-built, reusable components, patterns, principles, best practices, and guidelines that allows its users to build consistent web experiences across the entire Novartis pharmaceutical brand portfolio.

By using the pre-built components, teams spend less time designing and building — and more time customizing their web sites to address specific end user needs. The system serves patients, healthcare professionals, and internal brand teams simultaneously.

Cosentyx Brand Site — Tablet Mockup
Insert the tablet mockup screenshot showing the live Cosentyx (secukinumab) brand site built on the US Pharma Drupal DS — the "Here with you" hero with patient/HCP toggle nav.

Cosentyx.com — first brand site launched on the US Pharma Drupal Design System

40%
Session Duration Increase
Cosentyx (Rheum) saw a 40% increase in average session duration following design system launch.
15+
Components Built
Full MVP component library with 50+ variations spanning atoms through fully assembled page patterns.
50+
Component Variations
Each component built to accommodate brand customization, dark/light modes, and accessibility compliance.

4 Objectives That Shaped Every Decision

The design system was built to solve systemic problems across Novartis's digital portfolio — fragmented brand executions, inconsistent accessibility, slow time-to-market, and a cumbersome MLR review process. Four clear objectives anchored the work.

Why USPH Drupal DS — 4 Objectives Slide
Insert the blue-background "Why USPH Drupal DS?" slide showing the 4 numbered objectives on a Novartis brand blue (#1565C0) background with large white typography.

4 strategic objectives that anchored every design and development decision across the US Pharma DS

1
Ensure brand and design consistency throughout Novartis Brands and user interfaces with one central design system.
A single source of truth for all digital touchpoints — eliminating the inconsistency created by brand teams working in silos across agencies and platforms.
2
Meet performance, quality, compliance (MLR), and accessibility standards with industry-standard and tested UI components.
Every component is designed and validated to meet WCAG 2.1 AA accessibility standards, MLR compliance patterns, and Novartis technical performance benchmarks before release.
3
Reduce effort of UI Designers and Front-End Developers with a turn-key atomic UI library.
An atomic design library in both Figma and Drupal/React meant teams could assemble new brand experiences without rebuilding from scratch on every engagement.
4
Streamline the MLR process by providing a predictable, traceable library of design elements.
Pre-approved, traceable components reduced the number of MLR review cycles required per brand site and dramatically shortened approval timelines.

Targeted Business Benefits

The design system delivered measurable value beyond individual brand launches — transforming the economics and speed of digital production across the entire US Pharma portfolio.

  • A reusable web platform that enhances customer experience and omnichannel capability
  • Reduce costs on website design and builds
  • Reduce time to deliver and update websites
  • Improve time to market
  • More autonomy for brands
  • Increased high-value conversions
  • Achieve more reliable web performance benchmarks for SEO
  • Better digital experiences for HCPs & Patients

A System Built on Evidence

Every component and pattern in the design system was informed by structured research — usability testing with patients and HCPs, moderated sessions with CMS administrators, and continuous feedback loops embedded throughout the product lifecycle.

The 2022 Research Roadmap mapped user goals, key questions, and research stimuli across four quarters — covering navigation, findability, conversions, and future scalability.

Targeted Business Benefits — Laptop Visual
Insert the dark-background "Targeted Business Benefits" slide with the MacBook photo on wooden table at right — showing the bulleted benefit list on black background at left.

Business case for the US Pharma DS — reusability, cost reduction, speed, and better HCP/patient experiences

A System for Every Member of the Cross-Functional Team

The US Pharma DS serves designers, developers, marketers, and brand managers. Each audience gets the tools they need to contribute — without creating redundant work or inconsistent outputs.

Built for All Designers

The design system helps jumpstart designers on day one of any brand engagement. They have access to accessible, fully tested assets and guidance they can rely on to create cohesive experiences in line with Novartis standards.

Designers can quickly create tailored solutions for their brands using the atomic library design kit — saving time and money that could be spent on innovating new products or solutions.

Playbook
User interface designers browse all available UI Components and consult their related guidelines and best practices.
Figma Design Kit
Designers easily and rapidly compose screens by inserting ready-made UI Components from US Pharma DS.
Built for All Developers

The Drupal CMS design system provides reusable basic UI components in React and React Native so Front-End Developers can easily and rapidly implement user interfaces for desktop, tablet, and mobile devices.

Developers get the tools they need to build more sites in less time — saving them from creating the same base components repeatedly across engagements.

Drupal CMS
A site administrator can configure the look and feel of UI components without writing custom code — enabling more autonomy for brand and content teams.
Figma Playbook — Component Browser
Insert the Figma screenshot showing the component library browser (Atoms/Molecules list at left: Cta_buttons, Featured Content Card, Asset Left, etc.) with the Cosentyx brand component preview at right.

Figma Playbook — designers browse, consult guidelines, and insert ready-made UI components

Drupal CMS — Admin Configuration UI
Insert the Drupal CMS admin screenshot showing the "Configure block" modal with Banner Block settings (Chevron type, Value, Subtitle, CTA Buttons) and the Cosentyx photo gallery page behind it.

Drupal CMS admin — site administrators configure components without writing code

2022 Roadmap: Research-Driven Delivery

The 2022 roadmap organized work into three strategic themes — each with paired Research + Design and Development phases across Q1–Q4. Every feature shipped was grounded in validated user research before a single line of code was written.

01
Theme 1
Help Users Find Answers More Easily
Navigation MVP · Multi-Indication Navigation · Formulary Finder · HCP Rep Lookup · Search functionality
02
Theme 2
Increase High-Value Conversions
Cookie Overlay · IRMA-C Form Builder · Consent & Preference Management · Data Visualization (JS Library + Animated Assets) · Testimonial Block
03
Theme 3
Future Proofing & Scalability
Drupal CMS + Design System · MVP Enhancements · Content Management Enhancements · FE Grid Update (Material 3)
2022 Research Roadmap — Full Table
Insert the full "US Pharma – 2022 Research Roadmap" table showing Q1–Q4 columns across three strategic themes (Help Users / Increase Conversions / Future Proofing), with user goals and key questions per initiative, plus the "Identified areas to research further" sidebar.

2022 Research Roadmap — 12 research initiatives mapped across Q1–Q4 with user goals and key questions

2022 Feature Roadmap — Gantt Chart
Insert the "US Pharma – 2022 Design System Feature Roadmap" Gantt chart showing Research+Design and Development bars in orange across Q1–Q4 for all features, plus the "Features to be Researched & Prioritized" list at right.

2022 Feature Roadmap — paired Research+Design and Development phases tracked across all three strategic themes

Agency Onboarding Guide

An interactive guide to help agencies and brands design and launch a US Pharma website. Designed to onboard external partners quickly and ensure every new brand engagement starts from a consistent, compliant foundation.

This guide is a …
  • High-level resource for agencies and brands
  • Document for key contacts
  • Reference for design and development processes
  • Stepping stone with links to the Playbook and Design Toolkit (Figma files)
This guide is not a …
  • Guide on how to use the Drupal CMS
  • Design resource
Agency Onboarding Guide — Cover
Insert the dark navy "Agency Onboarding Guide — Creating a US Pharma website" cover slide with the Novartis logo, "Let's begin" CTA button, and abstract icon illustrations at right.

Agency Onboarding Guide — the interactive entry point for all agency partners and brand teams launching a US Pharma site

Our MVP Design System

15+
components
50+
variations
4
nav elements
Component List
  • Accordion
  • Footnote
  • Banners
  • Hero
  • Buttons
  • Informational Elements
  • Cards
  • ISI
  • Carousel (Photo Gallery)
  • List
  • Featured Content Cards
  • Modals
  • Free Form Content
  • Sticky CTA
  • Footer
Global Customization Options
  • Google Font support
  • Custom color palette
  • Dynamic vertical spacing
  • Icon libraries
  • Plug and play modular content blocks
Integrations and Connections
  • Google Tag Manager
  • Tealium
  • Kalturra Video Streaming
  • IRMA-C (later 2022)

UX Success Metrics — 4 Phases

Success was measured across four distinct phases — from initial usability testing of the MVP design system through long-term business impact assessment. Each phase targeted a different audience with purpose-built research stimuli and metrics.

Phase 1
Usability Testing MVP DS
AudienceEnd users — patients, caregivers, HCPs, support staff
StimuliStaging sites · Prototypes
MetricsTask completion rate · Time on task · Qualitative observations
0–3 months · Q2
Phase 2
Implementation & Adoption
AudienceDesigners, developers, CMS Admins (Novartis brand teams, AORs, CONEXTS)
StimuliFigma Design System files · Drupal CMS
MetricsComponent adoption · Monthly design hrs/cost · Designer/Developer satisfaction · Feedback loop
3–6 months · Q4
Phase 3
Performance
AudienceEnd users — patients, caregivers, HCPs, support staff
StimuliLive websites · Content strategy
MetricsSite load rate · Bounce rate · Avg session time · Accessibility score · Faster site speed · Increased SEO
Ongoing · Q4+
Phase 4
Business
AudienceDesigners, developers, CMS Admins (Novartis brand teams, AORs, CONEXTS)
StimuliFigma DS files · Drupal CMS · Live websites
MetricsCost savings to deliver websites · Time to market · Brand autonomy · Superior CX · High-value conversions
Ongoing · Q4+

Success — Cosentyx (Rheum)

The first major brand launch on the US Pharma Drupal Design System — Cosentyx (Rheumatology) — delivered measurable improvements across all key performance metrics. The results validated the design system approach and set the benchmark for future brand deployments.

40%
Increase in Avg Session Duration
Users engaged significantly longer with the redesigned Cosentyx experience following design system implementation.
1%
Drop in Bounce Rate
Improved navigation clarity and content findability reduced early exits from the brand site.
3%
Increase in Pages per Session
Patients and HCPs explored more content per visit — a signal of improved information architecture and user engagement.
Success Metrics — Cosentyx Outcome Stats
Insert the "Success! - Cosentyx (Rheum)" slide showing the three overlapping pink/magenta circles with 40% (increase in avg session duration), 1% (drop in bounce rate), and 3% (increase in pages per session) against a white background.

Cosentyx (Rheum) — measurable performance results post design system launch

Cosentyx Live Site — Clinical Content View
Insert the Cosentyx brand site screenshot showing the "Clinical manifestations" tab navigation (Joint relief, Long-term joint results, Axial, Enthesitis, Dactylitis, Skin) and "ALL-IN-ONE relief" section, demonstrating the design system in production.

Cosentyx.com — design system components live in production across the HCP experience